KATIONISCHES LIPID

European patent · EP3835287 · In force

Register entry

Publication number
EP3835287
Application number
EP19847498
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 8, 2019
Published
Jun 16, 2021
Granted
Oct 2, 2024
Protection ends at the latest
Aug 7, 2039
Next annual fee due
Aug 31, 2026
IPC classes
C07C 229/12 (2006.01)
C07C 271/20 (2006.01)
C12N 15/113 (2010.01)
C07C 219/06 (2006.01)
C07C 229/06 (2006.01)
Priority
JP 2018151583 10.08.2018
PCT application
PCT/JP2019/031411 08.08.2019
PCT publication
WO2020/032184 13.02.2020
Filing language
Japanese
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2025

    Change

    Published in Swissreg on 01.09.2025

  2. Aug 13, 2025

    Change

    Published in Swissreg on 13.08.2025

  3. Oct 30, 2024

    Agent entered

    Representative
    BOHEST AG, Holbeinstrasse 36-38, 4051 Basel

    Published in Swissreg on 30.10.2024

  4. Oct 3, 2024

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Parties

Holder

Takeda Pharmaceutical Company Limited

1-1, Doshomachi 4-chome Chuo-ku, Osaka-shi, Osaka 541-0045, JP

Agent

BOHEST AG

Holbeinstrasse 36-38, 4051 Basel

Inventor

MATSUMOTO Satoru

Fujisawa-shi, Kanagawa 251-0012, JP

OMORI Yoshimasa

Fujisawa-shi, Kanagawa 251-0012, JP

MINENO Masahiro

Fujisawa-shi, Kanagawa 251-0012, JP

SAWAI Yasuhiro

Fujisawa-shi, Kanagawa 251-0012, JP

KAKIMOTO Nozomu

Fujisawa-shi, Kanagawa 251-0012, JP

HOASHI Yasutaka

Fujisawa-shi, Kanagawa 251-0012, JP

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.